Found 7 matching trials
Evaluation of Safety of Candidate gD Vaccine, With or Without MPL in Healthy Herpes Simplex Virus-positive Adults
PHASE1The purpose of the study is to evaluate the safety and reactogenicity of ca...
Location
Multiple Locations
Study to Compare Safety and Immunogenicity of Commercial Scale Consistency Lots of Herpes Simplex Vaccine
PHASE3Evaluate, one month after the third dose, the lot-to-lot consistency of 3 d...
Location
GSK Investigational Site
Safety Evaluation of Herpes Simplex Candidate Vaccine (gD2t) With Adjuvant in HSV Seropositive / Seronegative Subjects
PHASE3This study will evaluate, versus a placebo, the safety of Herpes simplex ca...
Location
GSK Clinical Trials Call Center
Safety Study of Herpes Simplex Vaccine in HSV Seronegative and Seropositive Females Between 10 and 17 Years Old
PHASE3Main goal of this study is to compare the occurrence of serious adverse eve...
Location
GSK Investigational Site
Safety of a Herpes Simplex Candidate Vaccine (gD2t) With MPL and Its Efficacy to Prevent Genital Herpes Disease
PHASE3The purpose of the study is to evaluate the safety of Herpes Simplex candid...
Location
Multiple Locations
Humoral and Cellular Immune Response of Herpes Simplex (gD) Candidate Vaccines From 2 Different Cell Lines
PHASE1The purpose of the study is to compare, in healthy HSV seronegative and HSV...
Location
GSK Clinical Trials Call Center
Evaluation of Immunogenicity, Reactogenicity and Safety of Herpes Simplex (gD) Candidate Vaccine With/Without Adjuvant
PHASE2The purpose of the phase IIa study in healthy HSV seropositive and HSV sero...
Location
GSK Clinical Trials Call Center